Table 1.
Correlation between GSE1 levels and pathological features in HER2-positive gastric cancer patients.
| GSE1 levels (n (%)) | P | |||
|---|---|---|---|---|
| Parameter | n | Low | High | |
| Age (years) | ||||
| ≤60 | 15 | 6 (40.0) | 9 (60.0) | |
| >60 | 25 | 10 (40.0) | 15 (60.0) | 1.000 |
| Tumor size (cm) | ||||
| ≤5 | 23 | 10 (43.5) | 13 (56.5) | |
| >5 | 17 | 6 (35.3) | 11 (64.7) | 0.601 |
| Lymph node metastasis | ||||
| No | 18 | 11 (61.1) | 7 (38.9) | |
| Yes | 22 | 5 (22.7) | 17 (77.3) | 0.014 |
| Grade | ||||
| I-II | 24 | 9 (37.5) | 15 (62.5) | |
| III | 16 | 7 (43.8) | 9 (56.2) | 0.693 |
| Stage | ||||
| I-II | 17 | 10 (58.8) | 7 (41.2) | |
| III-IV | 23 | 6 (26.1) | 17 (73.9) | 0.037 |